Evidence map›Paper›PMID 29294068›Full record

ArticleNucleic acids research2018

Mu transpososome activity-profiling yields hyperactive MuA variants for highly efficient genetic and genome engineering.

Tiina S Rasila, Elsi Pulkkinen, Saija Kiljunen, Saija Haapa-Paananen, Maria I Pajunen, Anu Salminen, Lars Paulin, Mauno Vihinen, Phoebe A Rice, Harri Savilahti

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Tiina S RasilaDivision of Genetics and Physiology, Department of Biology, FI-20014 University of Turku, Turku, Finland.
Elsi PulkkinenDivision of Genetics and Physiology, Department of Biology, FI-20014 University of Turku, Turku, Finland.
Saija KiljunenDivision of Genetics and Physiology, Department of Biology, FI-20014 University of Turku, Turku, Finland.
Saija Haapa-PaananenDivision of Genetics and Physiology, Department of Biology, FI-20014 University of Turku, Turku, Finland.
Maria I PajunenDivision of Biochemistry and Biotechnology, Department of Biosciences, FI-00014 University of Helsinki, Helsinki, Finland.
Anu SalminenDepartment of Biochemistry, FI-20014 University of Turku, Turku, Finland.
Lars PaulinInstitute of Biotechnology, Viikki Biocenter, P. O. Box 56, FI-00014 University of Helsinki, Helsinki, Finland.
Mauno VihinenDepartment of Experimental Medical Science, Lund University, SE-221 84, Lund, Sweden.
Phoebe A RiceDepartment of Biochemistry and Molecular Biology, University of Chicago, Chicago, IL 60637, USA.
Harri SavilahtiDivision of Genetics and Physiology, Department of Biology, FI-20014 University of Turku, Turku, Finland.
University of Helsinki · FIUniversity of Turku · FILund University · SEUniversity of Chicago · US

Funding

Structural understanding of Mu transpositionR01GM101989 · NIGMS · UNIVERSITY OF CHICAGO · PI RICE, PHOEBE A · 2013 to 2016
$1.3M
6 · The paper itself

Abstract

The phage Mu DNA transposition system provides a versatile species non-specific tool for molecular biology, genetic engineering and genome modification applications. Mu transposition is catalyzed by MuA transposase, with DNA cleavage and integration reactions ultimately attaching the transposon DNA to target DNA. To improve the activity of the Mu DNA transposition machinery, we mutagenized MuA protein and screened for hyperactivity-causing substitutions using an in vivo assay. The individual activity-enhancing substitutions were mapped onto the MuA-DNA complex structure, containing a tetramer of MuA transposase, two Mu end segments and a target DNA. This analysis, combined with the varying effect of the mutations in different assays, implied that the mutations exert their effects in several ways, including optimizing protein-protein and protein-DNA contacts. Based on these insights, we engineered highly hyperactive versions of MuA, by combining several synergistically acting substitutions located in different subdomains of the protein. Purified hyperactive MuA variants are now ready for use as second-generation tools in a variety of Mu-based DNA transposition applications. These variants will also widen the scope of Mu-based gene transfer technologies toward medical applications such as human gene therapy. Moreover, the work provides a platform for further design of custom transposases.

Indexed as

DNA Transposable ElementsAmino Acid SubstitutionAnimalsCells, CulturedGenetic EngineeringGenomeMiceModels, MolecularMutationTransposasesDNA Transposable Elementsmu transposaseTransposases

Identifiers

PMID29294068
PMCPMC5961161
OpenAlexW2777582776

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.